MacroGenics Inc.(MGNX)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

MGNX MacroGenics Inc.

未开盘 11-18 16:00:00 EST

3.51

-0.06

-1.68%

盘后3.55

+0.04+1.14%

19:02 EST

最高3.71	最低3.50	成交量55.92万
今开3.58	昨收3.57	日振幅5.88%
总市值2.20亿	流通市值1.80亿	总股本6,276万
成交额199.04万	换手率1.09%	流通股本5,126万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

北京优虎网络科技有限公司

{"stockData":{"symbol":"MGNX","market":"US","secType":"STK","nameCN":"MacroGenics Inc.","latestPrice":3.51,"timestamp":1731963600000,"preClose":3.57,"halted":0,"volume":559184,"hourTrading":{"tag":"盘后","latestPrice":3.55,"preClose":3.51,"latestTime":"19:02 EST","volume":11666,"amount":40999.13,"timestamp":1731974553417},"delay":0,"floatShares":51261726,"shares":62763448,"eps":-1.563469,"marketStatus":"未开盘","marketStatusCode":0,"change":-0.06,"latestTime":"11-18 16:00:00 EST","open":3.58,"high":3.71,"low":3.5,"amount":1990371.552056,"amplitude":0.058824,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-1.563469,"exchange":"NASDAQ","tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1732006800000},"adr":0,"listingDate":1381377600000,"adjPreClose":3.57,"adrRate":0,"preHourTrading":{"tag":"盘前","latestPrice":3.66,"preClose":3.57,"latestTime":"08:46 EST","volume":767,"amount":2807.2096455,"timestamp":1731937609853},"postHourTrading":{"tag":"盘后","latestPrice":3.55,"preClose":3.51,"latestTime":"19:02 EST","volume":11666,"amount":40999.13,"timestamp":1731974553417},"volumeRatio":0.964902,"impliedVol":0.5665,"impliedVolPercentile":0.1514},"requestUrl":"/m/hq/s/MGNX","defaultTab":"news","newsList":[{"id":"2483378228","title":"Macrogenics, Inc.盘中异动 快速下跌5.00%报3.90美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2483378228","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2483378228?lang=zh_cn&edition=full","pubTime":"2024-11-14 01:42","pubTimestamp":1731519763,"startTime":"0","endTime":"0","summary":"北京时间2024年11月14日01时42分，Macrogenics, Inc.股票出现波动，股价快速下挫5.00%。Macrogenics, Inc.股票所在的生物技术行业中，整体跌幅为0.22%。Macrogenics, Inc.公司简介：Macrogenics Inc是一家生物技术公司，专注于发现和开发用于治疗癌症的基于抗体的疗法。其产品包括MARGENZA，用于治疗患有转移性HER2阳性乳腺癌的成年患者。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241114014243971a659e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241114014243971a659e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["MGNX","BK4139"],"gpt_icon":0},{"id":"2482808786","title":"Macrogenics, Inc.盘中异动 快速跳水5.01%报4.17美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2482808786","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2482808786?lang=zh_cn&edition=full","pubTime":"2024-11-12 23:38","pubTimestamp":1731425908,"startTime":"0","endTime":"0","summary":"北京时间2024年11月12日23时38分，Macrogenics, Inc.股票出现波动，股价急速下跌5.01%。截至发稿，该股报4.17美元/股，成交量9.8498万股，换手率0.16%，振幅4.67%。Macrogenics, Inc.股票所在的生物技术行业中，整体跌幅为0.31%。Macrogenics, Inc.公司简介：Macrogenics Inc是一家生物技术公司，专注于发现和开发用于治疗癌症的基于抗体的疗法。其产品包括MARGENZA，用于治疗患有转移性HER2阳性乳腺癌的成年患者。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241112233829971a60ee&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241112233829971a60ee&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","MGNX"],"gpt_icon":0},{"id":"2482331267","title":"Macrogenics, Inc.2024财年第三财季实现净利润56.31百万美元，同比增加220.85%","url":"https://stock-news.laohu8.com/highlight/detail?id=2482331267","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2482331267?lang=zh_cn&edition=full","pubTime":"2024-11-11 00:01","pubTimestamp":1731254504,"startTime":"0","endTime":"0","summary":"11月11日，Macrogenics, Inc.公布财报，公告显示公司2024财年第三财季净利润为56.31百万美元，同比增加220.85%；其中营业收入为1.11亿美元，同比增加967.31%，每股基本收益为0.90美元。机构评级：截至2024年11月11日，当前有7家机构对Macrogenics, Inc.目标价做出预测，其中目标均价为7.29美元，其中最低目标价为4.00美元，最高目标价为14.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241111000229a229e47b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241111000229a229e47b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["MGNX"],"gpt_icon":0},{"id":"2482489977","title":"Macrogenics, Inc.盘中异动 早盘股价大跌5.04%报4.24美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2482489977","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2482489977?lang=zh_cn&edition=full","pubTime":"2024-11-09 00:08","pubTimestamp":1731082094,"startTime":"0","endTime":"0","summary":"北京时间2024年11月09日00时08分，Macrogenics, Inc.股票出现异动，股价大幅跳水5.04%。截至发稿，该股报4.24美元/股，成交量18.3691万股，换手率0.29%，振幅6.50%。Macrogenics, Inc.股票所在的生物技术行业中，整体涨幅为0.65%。Macrogenics, Inc.公司简介：Macrogenics Inc是一家生物技术公司，专注于发现和开发用于治疗癌症的基于抗体的疗法。其产品包括MARGENZA，用于治疗患有转移性HER2阳性乳腺癌的成年患者。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241109000815a224fc7a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241109000815a224fc7a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","MGNX"],"gpt_icon":0},{"id":"2481985631","title":"Macrogenics, Inc.盘中异动 急速拉升25.73%","url":"https://stock-news.laohu8.com/highlight/detail?id=2481985631","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2481985631?lang=zh_cn&edition=full","pubTime":"2024-11-06 22:32","pubTimestamp":1730903575,"startTime":"0","endTime":"0","summary":"北京时间2024年11月06日22时32分，Macrogenics, Inc.股票出现异动，股价大幅上涨25.73%。Macrogenics, Inc.股票所在的生物技术行业中，整体涨幅为0.49%。其相关个股中，Sonnet Biotherapeutics Holdings, Inc.、Lixte Biotechnology Holdings  Inc C/Wts 30/11/2025 、Sab Biotherapeutics Inc C/Wts 22/10/2026 涨幅较大，Sonnet Biotherapeutics Holdings, Inc.、Elevai Labs, Inc.、Zyversa Therapeutics, Inc.较为活跃，换手率分别为1068.99%、99.53%、51.62%，振幅较大的相关个股有Psyence Biomedical Ltd C/Wts 25/01/2029、Sonnet Biotherapeutics Holdings, Inc.、Macrogenics, Inc.，振幅分别为32.45%、30.64%、14.59%。Macrogenics, Inc.公司简介：Macrogenics Inc是一家生物技术公司，专注于发现和开发用于治疗癌症的基于抗体的疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024110622325595bddb7e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024110622325595bddb7e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","MGNX"],"gpt_icon":0},{"id":"2481454553","title":"Macrogenics, Inc.盘中异动 快速下跌5.43%报3.66美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2481454553","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2481454553?lang=zh_cn&edition=full","pubTime":"2024-11-05 03:09","pubTimestamp":1730747356,"startTime":"0","endTime":"0","summary":"北京时间2024年11月05日03时09分，Macrogenics, Inc.股票出现异动，股价急速下跌5.43%。截至发稿，该股报3.66美元/股，成交量19.287万股，换手率0.31%，振幅5.56%。Macrogenics, Inc.股票所在的生物技术行业中，整体跌幅为0.29%。Macrogenics, Inc.公司简介：Macrogenics Inc是一家生物技术公司，专注于发现和开发用于治疗癌症的基于抗体的疗法。其产品包括MARGENZA，用于治疗患有转移性HER2阳性乳腺癌的成年患者。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241105030916971a43c3&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241105030916971a43c3&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["MGNX","BK4139"],"gpt_icon":0},{"id":"2480801818","title":"MacroGenics Inc    预计每股收益 21 美分 - 财报前瞻","url":"https://stock-news.laohu8.com/highlight/detail?id=2480801818","media":"Reuters","labels":["preview"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2480801818?lang=zh_cn&edition=full","pubTime":"2024-11-02 11:54","pubTimestamp":1730519692,"startTime":"0","endTime":"0","summary":"   * MacroGenics Inc    预计将在11月5日公布截至0001年1月1日的季度收入报告。* 根据LSEG的数据，7位分析师的平均预期显示，这家总部位于马里兰州罗克维尔的公司的营收预计将从去年同期的1040万美元增长632.1%，达到7611.5万美元。* LSEG分析师对MacroGenics公司的平均预期为每股收益21美分。* 华尔街对 MacroGenics Inc 的 12 个月目标价中位数为 8.00 美元，高于其上一次收盘价 3.87 美元。11月2日 - 上一季度业绩。除非另有说明，否则所有数据均以美元为单位。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"MacroGenics Inc    预计每股收益 21 美分 - 财报前瞻","news_tag":"preview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MGNX"],"gpt_icon":0},{"id":"2480314838","title":"Macrogenics, Inc.盘中异动 早盘大幅上涨5.19%报3.85美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2480314838","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2480314838?lang=zh_cn&edition=full","pubTime":"2024-11-01 22:57","pubTimestamp":1730473021,"startTime":"0","endTime":"0","summary":"北京时间2024年11月01日22时57分，Macrogenics, Inc.股票出现异动，股价急速上涨5.19%。截至发稿，该股报3.85美元/股，成交量13.0788万股，换手率0.21%，振幅4.92%。Macrogenics, Inc.股票所在的生物技术行业中，整体涨幅为0.40%。Macrogenics, Inc.公司简介：Macrogenics Inc是一家生物技术公司，专注于发现和开发用于治疗癌症的基于抗体的疗法。其产品包括MARGENZA，用于治疗患有转移性HER2阳性乳腺癌的成年患者。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024110122570198e4009c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024110122570198e4009c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["MGNX","BK4139"],"gpt_icon":0},{"id":"2479332760","title":"Macrogenics, Inc.盘中异动 大幅拉升5.00%","url":"https://stock-news.laohu8.com/highlight/detail?id=2479332760","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2479332760?lang=zh_cn&edition=full","pubTime":"2024-10-31 21:56","pubTimestamp":1730382991,"startTime":"0","endTime":"0","summary":"北京时间2024年10月31日21时56分，Macrogenics, Inc.股票出现异动，股价急速拉升5.00%。Macrogenics, Inc.股票所在的生物技术行业中，整体跌幅为2.37%。其相关个股中，Psyence Biomedical Ltd C/Wts 25/01/2029、Ocean Biomedical Inc C/Wts 14/02/2028 、180 Life Sciences Corp C/Wts 07/11/2025涨幅较大，Aditxt, Inc.、Evogene Ltd.、Palisade Bio, Inc.较为活跃，换手率分别为213.37%、213.33%、153.76%，振幅较大的相关个股有Cingulate Inc C/Wts 10/12/2026 、180 Life Sciences Corp C/Wts 07/11/2025、Psyence Biomedical Ltd C/Wts 25/01/2029，振幅分别为39.30%、29.67%、28.17%。Macrogenics, Inc.公司简介：Macrogenics Inc是一家生物技术公司，专注于发现和开发用于治疗癌症的基于抗体的疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241031215631a202384d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241031215631a202384d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","MGNX"],"gpt_icon":0},{"id":"2479554132","title":"Macrogenics, Inc.盘中异动 下午盘股价大跌5.11%报3.34美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2479554132","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2479554132?lang=zh_cn&edition=full","pubTime":"2024-10-30 03:20","pubTimestamp":1730229649,"startTime":"0","endTime":"0","summary":"北京时间2024年10月30日03时20分，Macrogenics, Inc.股票出现异动，股价急速跳水5.11%。截至发稿，该股报3.34美元/股，成交量46.3288万股，换手率0.74%，振幅5.54%。Macrogenics, Inc.股票所在的生物技术行业中，整体跌幅为0.31%。Macrogenics, Inc.公司简介：Macrogenics Inc是一家生物技术公司，专注于发现和开发用于治疗癌症的基于抗体的疗法。其产品包括MARGENZA，用于治疗患有转移性HER2阳性乳腺癌的成年患者。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241030032049971a2fff&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241030032049971a2fff&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["MGNX","BK4139"],"gpt_icon":0},{"id":"2478668293","title":"Macrogenics, Inc.盘中异动 下午盘大幅跳水5.08%","url":"https://stock-news.laohu8.com/highlight/detail?id=2478668293","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2478668293?lang=zh_cn&edition=full","pubTime":"2024-10-25 01:18","pubTimestamp":1729790283,"startTime":"0","endTime":"0","summary":"北京时间2024年10月25日01时18分，Macrogenics, Inc.股票出现异动，股价急速下挫5.08%。Macrogenics, Inc.股票所在的生物技术行业中，整体跌幅为0.21%。其相关个股中，Monopar Therapeutics Inc.、Quince Therapeutics, Inc.、Psyence Biomedical Ltd C/Wts 25/01/2029涨幅较大，Qualigen Therapeutics, Inc.、Monopar Therapeutics Inc.、Cns Pharmaceuticals, Inc.较为活跃，换手率分别为278.54%、234.20%、193.24%，振幅较大的相关个股有Monopar Therapeutics Inc.、Psyence Biomedical Ltd C/Wts 25/01/2029、Qualigen Therapeutics, Inc.，振幅分别为679.91%、78.77%、71.78%。Macrogenics, Inc.公司简介：Macrogenics Inc是一家生物技术公司，专注于发现和开发用于治疗癌症的基于抗体的疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024102501180398e3e4d4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024102501180398e3e4d4&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["MGNX","BK4139"],"gpt_icon":0},{"id":"2477889167","title":"Macrogenics, Inc.盘中异动 股价大跌5.11%","url":"https://stock-news.laohu8.com/highlight/detail?id=2477889167","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2477889167?lang=zh_cn&edition=full","pubTime":"2024-10-22 01:30","pubTimestamp":1729531807,"startTime":"0","endTime":"0","summary":"北京时间2024年10月22日01时30分，Macrogenics, Inc.股票出现波动，股价急速下跌5.11%。Macrogenics, Inc.股票所在的生物技术行业中，整体跌幅为0.74%。其相关个股中，Genprex, Inc.、Biovie Inc.、Gri Bio, Inc.涨幅较大，Genprex, Inc.、Gri Bio, Inc.、Biovie Inc.较为活跃，换手率分别为8829.09%、3436.93%、1565.56%，振幅较大的相关个股有Genprex, Inc.、Biovie Inc.、Psyence Biomedical Ltd C/Wts 25/01/2029，振幅分别为369.73%、157.02%、148.15%。Macrogenics, Inc.公司简介：Macrogenics Inc是一家生物技术公司，专注于发现和开发用于治疗癌症的基于抗体的疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024102201300898e3d968&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024102201300898e3d968&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["MGNX","BK4139"],"gpt_icon":0},{"id":"2474014164","title":"Macrogenics, Inc.盘中异动 快速拉升5.21%报3.94美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2474014164","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2474014164?lang=zh_cn&edition=full","pubTime":"2024-10-12 00:20","pubTimestamp":1728663624,"startTime":"0","endTime":"0","summary":"北京时间2024年10月12日00时20分，Macrogenics, Inc.股票出现波动，股价急速上涨5.21%。截至发稿，该股报3.94美元/股，成交量17.2695万股，换手率0.28%，振幅6.68%。Macrogenics, Inc.股票所在的生物技术行业中，整体涨幅为1.41%。Macrogenics, Inc.公司简介：Macrogenics Inc是一家生物技术公司，专注于发现和开发用于治疗癌症的基于抗体的疗法。其产品包括MARGENZA，用于治疗患有转移性HER2阳性乳腺癌的成年患者。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202410120020249719fb8c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202410120020249719fb8c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["MGNX","BK4139"],"gpt_icon":0},{"id":"2471385473","title":"Macrogenics, Inc.盘中异动 早盘股价大涨5.02%","url":"https://stock-news.laohu8.com/highlight/detail?id=2471385473","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2471385473?lang=zh_cn&edition=full","pubTime":"2024-09-30 21:50","pubTimestamp":1727704228,"startTime":"0","endTime":"0","summary":"北京时间2024年09月30日21时50分，Macrogenics, Inc.股票出现波动，股价快速拉升5.02%。Macrogenics, Inc.股票所在的生物技术行业中，整体跌幅为0.21%。Macrogenics, Inc.公司简介：Macrogenics Inc是一家生物技术公司，专注于发现和开发用于治疗癌症的基于抗体的疗法。其产品包括MARGENZA，用于治疗患有转移性HER2阳性乳腺癌的成年患者。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240930215029a1ddb537&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240930215029a1ddb537&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","MGNX"],"gpt_icon":0},{"id":"2470059367","title":"Macrogenics, Inc.盘中异动 临近收盘股价大涨5.10%报3.20美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2470059367","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2470059367?lang=zh_cn&edition=full","pubTime":"2024-09-28 03:52","pubTimestamp":1727466722,"startTime":"0","endTime":"0","summary":"北京时间2024年09月28日03时52分，Macrogenics, Inc.股票出现异动，股价急速拉升5.10%。截至发稿，该股报3.20美元/股，成交量44.3105万股，换手率0.71%，振幅4.11%。Macrogenics, Inc.股票所在的生物技术行业中，整体跌幅为1.31%。Macrogenics, Inc.公司简介：Macrogenics Inc是一家生物技术公司，专注于发现和开发用于治疗癌症的基于抗体的疗法。其产品包括MARGENZA，用于治疗患有转移性HER2阳性乳腺癌的成年患者。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202409280352029719d2e8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202409280352029719d2e8&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["MGNX","BK4139"],"gpt_icon":0},{"id":"2468577304","title":"Macrogenics, Inc.盘中异动 大幅拉升5.45%","url":"https://stock-news.laohu8.com/highlight/detail?id=2468577304","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2468577304?lang=zh_cn&edition=full","pubTime":"2024-09-19 21:31","pubTimestamp":1726752662,"startTime":"0","endTime":"0","summary":"北京时间2024年09月19日21时31分，Macrogenics, Inc.股票出现波动，股价快速拉升5.45%。Macrogenics, Inc.股票所在的生物技术行业中，整体涨幅为0.87%。其相关个股中，Exicure, Inc.、Psyence Biomedical Ltd C/Wts 25/01/2029、Humacyte Inc C/Wts 27/08/2026 涨幅较大，Galmed Pharmaceuticals Ltd.、Exicure, Inc.、Psyence Biomedical Ltd.较为活跃，换手率分别为1021.10%、332.11%、69.49%，振幅较大的相关个股有Exicure, Inc.、Autolus Therapeutics Plc、Renovaro Inc.，振幅分别为18.34%、11.37%、9.65%。Macrogenics, Inc.公司简介：Macrogenics Inc是一家生物技术公司，专注于发现和开发用于治疗癌症的基于抗体的疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202409192131039719bd54&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202409192131039719bd54&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","MGNX"],"gpt_icon":0},{"id":"2468823055","title":"BUZZ-数据显示前列腺癌药物安全性恶化，MacroGenics业绩下滑","url":"https://stock-news.laohu8.com/highlight/detail?id=2468823055","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2468823055?lang=zh_cn&edition=full","pubTime":"2024-09-17 01:32","pubTimestamp":1726507938,"startTime":"0","endTime":"0","summary":"    9月16日 - ** 药物开发商MacroGenics   的股价在下午的交易中下跌了9%，至3.37美元。** 该公司周日 在一次医学会议上公布了 一项中期试验的最新安全性和有效性数据，该试验针对一种前列腺癌患者，测试其实验性抗体药物--conjugate vobra duo。** TD Cowen分析师称，虽然该药物的疗效似乎具有竞争力，但即使药物剂量得到优化且试验取得成功，vobra duo的使用也可能仅限于晚期患者。** 包括本交易日的走势在内，MGNX 的股价今年以来下跌了约 65","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","MGNX"],"gpt_icon":0},{"id":"2460805709","title":"Macrogenics, Inc.盘中异动 下午盘大幅拉升5.11%报3.40美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2460805709","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2460805709?lang=zh_cn&edition=full","pubTime":"2024-08-20 01:40","pubTimestamp":1724089255,"startTime":"0","endTime":"0","summary":"北京时间2024年08月20日01时40分，Macrogenics, Inc.股票出现波动，股价快速拉升5.11%。Macrogenics, Inc.股票所在的生物技术行业中，整体涨幅为0.75%。Macrogenics, Inc.公司简介：Macrogenics Inc是一家生物技术公司，专注于发现和开发用于治疗癌症的基于抗体的疗法。其产品包括MARGENZA，用于治疗患有转移性HER2阳性乳腺癌的成年患者。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024082001405698e35668&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024082001405698e35668&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BK4539","MGNX"],"gpt_icon":1},{"id":"2459107619","title":"Macrogenics, Inc.盘中异动 大幅下跌5.24%","url":"https://stock-news.laohu8.com/highlight/detail?id=2459107619","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2459107619?lang=zh_cn&edition=full","pubTime":"2024-08-15 00:25","pubTimestamp":1723652756,"startTime":"0","endTime":"0","summary":"北京时间2024年08月15日00时25分，Macrogenics, Inc.股票出现异动，股价急速下挫5.24%。Macrogenics, Inc.股票所在的生物技术行业中，整体涨幅为0.14%。Macrogenics, Inc.公司简介：Macrogenics Inc是一家生物技术公司，专注于发现和开发用于治疗癌症的基于抗体的疗法。其产品包括MARGENZA，用于治疗患有转移性HER2阳性乳腺癌的成年患者。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240815002556aefec14a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240815002556aefec14a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["MGNX","BK4139"],"gpt_icon":0},{"id":"2459183431","title":"Macrogenics, Inc.盘中异动 股价大涨5.07%","url":"https://stock-news.laohu8.com/highlight/detail?id=2459183431","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2459183431?lang=zh_cn&edition=full","pubTime":"2024-08-13 23:06","pubTimestamp":1723561582,"startTime":"0","endTime":"0","summary":"北京时间2024年08月13日23时06分，Macrogenics, Inc.股票出现波动，股价快速拉升5.07%。Macrogenics, Inc.股票所在的生物技术行业中，整体涨幅为1.87%。其相关个股中，Nls Pharmaceutics Ltd C/Wts 02/02/2026、Cardio Diagnostics Holdings Inc C/Wts  To Pur Com、Psyence Biomedical Ltd C/Wts 25/01/2029涨幅较大，Genprex, Inc.、冠科美博、Oragenics Inc.较为活跃，换手率分别为132.37%、120.29%、28.19%，振幅较大的相关个股有冠科美博、Psyence Biomedical Ltd C/Wts 25/01/2029、Tempest Therapeutics, Inc.，振幅分别为59.51%、40.95%、39.71%。Macrogenics, Inc.公司简介：Macrogenics Inc是一家生物技术公司，专注于发现和开发用于治疗癌症的基于抗体的疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240813230622942004a7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240813230622942004a7&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","MGNX"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.macrogenics.com","stockEarnings":[{"period":"1week","weight":-0.2005},{"period":"1month","weight":-0.1247},{"period":"3month","weight":-0.0304},{"period":"6month","weight":-0.2532},{"period":"1year","weight":-0.5375},{"period":"ytd","weight":-0.6351}],"compareEarnings":[{"period":"1week","weight":-0.0177},{"period":"1month","weight":0.0061},{"period":"3month","weight":0.0527},{"period":"6month","weight":0.1101},{"period":"1year","weight":0.3047},{"period":"ytd","weight":0.2374}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Macrogenics, Inc.于2000年8月14日在美国特拉华州注册成立。该公司是一家临床阶段的生物制药公司，致力于发现和开发新型的以单克隆抗体为基础的疗法，用于治疗癌症和自身免疫性疾病。该公司通过其专有的一套下一代抗体技术平台，开发候选产品，并相信这个平台可以提高单克隆抗体和抗体衍生分子的性能。借助疾病生物学和免疫介导机制的知识，该公司已确定这些候选产品或许能应对现有疗法无法治疗的特定疾病所带来的挑战。公司既开发了针对新癌症靶点的分化分子，又提升了已上市药品的功效。","yearOnYearQuotes":[{"month":1,"riseRate":0.272727,"avgChangeRate":-0.011067},{"month":2,"riseRate":0.636364,"avgChangeRate":0.087848},{"month":3,"riseRate":0.363636,"avgChangeRate":-0.042293},{"month":4,"riseRate":0.454545,"avgChangeRate":-0.021288},{"month":5,"riseRate":0.363636,"avgChangeRate":0.018479},{"month":6,"riseRate":0.545455,"avgChangeRate":0.060585},{"month":7,"riseRate":0.181818,"avgChangeRate":-0.04313},{"month":8,"riseRate":0.454545,"avgChangeRate":0.017445},{"month":9,"riseRate":0.090909,"avgChangeRate":-0.07197},{"month":10,"riseRate":0.545455,"avgChangeRate":0.016508},{"month":11,"riseRate":0.666667,"avgChangeRate":0.127568},{"month":12,"riseRate":0.454545,"avgChangeRate":-0.00459}],"exchange":"NASDAQ","name":"MacroGenics Inc.","nameEN":"Macrogenics"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.29.1","shortVersion":"4.29.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"MacroGenics Inc.(MGNX)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供MacroGenics Inc.(MGNX)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"MacroGenics Inc.,MGNX,MacroGenics Inc.股票,MacroGenics Inc.股票老虎,MacroGenics Inc.股票老虎国际,MacroGenics Inc.行情,MacroGenics Inc.股票行情,MacroGenics Inc.股价,MacroGenics Inc.股市,MacroGenics Inc.股票价格,MacroGenics Inc.股票交易,MacroGenics Inc.股票购买,MacroGenics Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"MacroGenics Inc.(MGNX)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供MacroGenics Inc.(MGNX)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}